🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.

Several experts said the demand for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.

Service Response and Material Removal

Based on TikTok, the platform has removed violative content and banned associated keywords and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Costs

Within these communities, posts show black plastic packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially significant medical dangers”.